Potential medication errors in the context of benefit risk balance and risk minimisation measures

Current effective version

PDF iconAdopted position paper

Reference numberEMA/CHMP/277591/2013
Effective from01/06/2013
KeywordsMedication error, similar medicinal products, reference product, product confusion, error prevention
DescriptionThis document focuses on the impact of potential medication errors on the benefit-risk balance of medicinal products introducing changes in relation to an authorised/established product containing the same active substance.

Document history

First version

Current version

PDF iconAdopted position paper

Overview of comments

PDF iconDraft position paper

In operation: 01/06/2013–present

Published: 07/06/2013

Published: 01/06/2012

Related content

How useful was this page?

Add your rating